$sgmo
SGMO's ST-920 Fabry disease trial shows positive data, nearing BLA submission, while stock performance and investor optimism rise. Discussions also focus on potential partnerships and monetization strategies.
About $sgmo
SGMO is a biotechnology company focused on genomic medicine, particularly gene therapies.
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Month: [-------] -28%
[--] Months: [---------] +7.60%
[--] Year: [----------] -9%
1-Year High: [-------] on 2025-04-04
1-Year Low: [-----] on 2025-03-02
Engagements by network (24h): X: [-----] Reddit: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
1-Year High: [---] on 2025-12-08
1-Year Low: [--] on 2025-05-25
Mentions by network (24h): X: [---] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $sgmo in the last [--] hours which is down 9.50% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-11-24
1-Year Low: [--] on 2025-05-25
The most influential creators that mention $sgmo in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Franca_ole | [--] | [-----] | [--] | [-----] |
| @ZinselmeyerB | [--] | [-----] | [--] | [---] |
| @BiotechAnalysst | [--] | [-----] | [--] | [---] |
| @GothamGirl_1 | [--] | [--] | [--] | [---] |
| @Brencslace | [--] | [---] | [--] | [---] |
| @Soeren_Berlin | [--] | [-----] | [--] | [---] |
| @Roqaya939738 | [--] | [---] | [--] | [---] |
| @meangenebio | [--] | [---] | [--] | [---] |
| @retaal1932 | [--] | [--] | [--] | [---] |
| @ayasalmny | [--] | [--] | [--] | [---] |
Sentiment: 85%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 85%
Daily Average: 80%
[--] Month: 84% +15%
[--] Months: 84% +1%
[--] Year: 84% -5%
1-Year High: 100% on 2025-03-04
1-Year Low: 29% on 2025-12-14
Most Supportive Themes:
- Positive Clinical Trial Data and Regulatory Progress: (30%) Posts highlight positive developments in clinical trials, particularly for ST-920 in Fabry disease, and mention progress towards BLA submissions and FDA approvals.
- Stock Performance and Investor Sentiment: (25%) Several posts discuss the stock's recent performance, including significant gains and investor optimism, with some anticipating further price increases.
- Partnership and Monetization Potential: (20%) Discussions revolve around the potential for SGMO to monetize its therapies, with mentions of potential partnerships and the likelihood of payors covering treatments.
Most Critical Themes:
- Competition and Market Landscape: (15%) Posts acknowledge competition, particularly from Sanofi's Fabry trial failure, but also highlight SGMO's unique position and potential to be the sole curative option.
- Valuation and Investment Strategy: (10%) Some investors express a long-term view, emphasizing the need for deep due diligence and caution against chasing short-term gains, while others see undervaluation.
Top $sgmo Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"@ZinselmeyerB @BiotechAnalysst @PeterWardJD @Soeren_Berlin Bernd many are underestimating the implications here putting us back in compliance lowers our margin maintenance ratio to around 50% most brokers have us at 100% leaving a large amount of liquidity on the sidelines I guarantee most would lever up on $SGMO if given the chance 🙂"
X Link @ste4103 2026-02-14T16:52Z [--] followers, [---] engagements
"@PeterWardJD @Soeren_Berlin $SGMO reverse split panic is overdone. If its simply a compliance move and the revenue/strategy path is clear (THAT IS THE CRUX); its cosmetics; not fundamentals. [--] $0.40 [--] $4.00. Same pie just sliced differently"
X Link @ZinselmeyerB 2026-02-14T16:34Z [----] followers, [----] engagements
"$SXTC $GXAI $LICN $NUKK $BABA $SATL $SGMO $AMD $DJT $PLTR $AAPL $GOOGL $META $SPY $BHAT $EYEN $SFHG $WINT $SYTA $QBTS $NRSX $BLMZ $QIPT $EYEN $SATX $VGZ $AS $EDBL 🔥🔥🔥 #_ https://x.com/messages/composerecipient_id=1913058180440920064 https://x.com/messages/composerecipient_id=1913058180440920064"
X Link @Yassin111Y 2026-02-14T12:04Z [---] followers, [---] engagements
"@ZinselmeyerB @BiotechAnalysst $CRSP $SGMO @UrnovFyodor $SGMO NOT suing $CRSP to enforce its BCL11A patent of which you led discovery so that patients suffering from Beta-thal and sickle cell could benefit from ongoing research being done by CRSP via CTX001. That decision is an action; and as such is beneficence in research. https://t.co/WYLeuPfH56 @UrnovFyodor $SGMO NOT suing $CRSP to enforce its BCL11A patent of which you led discovery so that patients suffering from Beta-thal and sickle cell could benefit from ongoing research being done by CRSP via CTX001. That decision is an action; and"
X Link @Corona_N_Lyme 2026-02-13T21:13Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing